Technological Advances in Health and Disease Research - Genetic TOE

USD 1,500

* Required Fields

USD 1,500


Be the first to review this product

Collaborations across the healthcare community, consisting of academicians, large pharmaceutical companies as well as smaller biotechnology start ups are constantly increasing. This collaborative landscape approach has resulted in the development of several initiatives as well as technological innovations. These technological innovations are rather prominent in the genetic space, with a recent collaboration leading to the development of genome wide association studies across the African American demographic. Genetic technologies have even started to impact nutritional sciences, with the capability of innovative cell culture systems for cultivation of specific nutritional characteristics in food.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Big pharma, collaborations, genetic technologies, nutritional sciences, cultivation techniques, 3D printing, cell cultures

Table of Contents

Technological Advances in Health and Disease Research - Genetic TOETechnology ProfilesBig Pharma Collaborations for Cancer Moonshot InitiativeReference Datasets for Health Research in African Americans3D Printed Cell Cultures for Antioxidant and Vitamin Production Big Data Collaboration for Precision OncologyAppendixPatent ScenarioPatent Scenario (Continued)Industry Interactions




Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.